Search

GlaxoSmithKline PLC

Gesloten

SectorGezondheidszorg

1,771.5 -0.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1769

Max

1804

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.4B

435M

Verkoop

780M

8.4B

K/W

Sectorgemiddelde

15.572

56.597

EPS

0.51

Dividendrendement

3.68

Winstmarge

5.173

Werknemers

66,841

EBITDA

-153M

2.6B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+17.69% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

3.68%

2.18%

Volgende Winsten

28 okt 2026

Volgende dividenddatum

8 okt 2026

Volgende Ex Dividend datum

12 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-4.9B

74B

Vorige openingsprijs

1771.7

Vorige sluitingsprijs

1771.5

Nieuwssentiment

By Acuity

43%

57%

113 / 339 Rangschikking in Healthcare

GlaxoSmithKline PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 sep 2026, 23:56 UTC

News

Ionis Pharmaceuticals received FDA approval for ZANVASTRO. Shares are higher in after-market trading, reflecting positive sentiment despite a setback in a partnered trial.

11 sep 2026, 23:41 UTC

News
Social Media

Johnson & Johnson shares higher after news of Apollo Global Management's interest in acquiring its $20 billion orthopedics unit, DePuy Synthes.

11 sep 2026, 23:26 UTC

News

Bentley Systems declared a quarterly dividend of $0.07 per share, scheduled for September 29, 2026, with shares trading higher in after-market hours.

11 sep 2026, 23:16 UTC

News

Carriage Services Inc shares higher in after-hours trading, following a Friday close. Analysts set an average price target of $51.00, indicating potential upside.

11 sep 2026, 23:06 UTC

Macro Event
News

Ethereum is higher in Friday's session, recovering after four days of declines. The asset remains above its 20-day moving average amid rising inflation pressures.

11 sep 2026, 23:06 UTC

Macro Event
News

Ethereum is rising during Friday's session, supported by recent inflation data and fluctuating crude oil prices. The asset remains above its 20-day moving average.

11 sep 2026, 23:01 UTC

Social Media
News

Oracle Corp's after-market shares declined following a $700 million expansion of its restructuring plan, raising total costs to $2.8 billion amid financial pressures.

11 sep 2026, 23:01 UTC

News

Nasdaq Inc. shares rose in after-market trading following a $100 million investment in Payward to develop Nasdaq Equity Tokens, set to launch in 2027.

11 sep 2026, 23:01 UTC

Social Media
News

Corning Inc shares fell in after-market trading following a $2 billion stock offering announcement, raising investor concerns about potential dilution.

11 sep 2026, 22:51 UTC

News
Social Media

Scholar Rock Holding Corp gains after FDA approves ISEMBYLD for spinal muscular atrophy, with a U.S. launch set to begin shortly.

11 sep 2026, 22:01 UTC

News

Estée Lauder Companies secured a legal win against Walmart over counterfeit products, but shares are trading lower in after-market hours amid ongoing retail sector concerns.

11 sep 2026, 21:31 UTC

News

Warner Bros Discovery Inc. shares are higher in after-market hours following reports of Paramount's settlement talks with state attorneys general over its acquisition proposal.

11 sep 2026, 20:51 UTC

News

Ralph Lauren Corp's Board declared a quarterly dividend of $1.00 per share, and shares are trading higher in after-market hours.

11 sep 2026, 20:09 UTC

News

1-800-Flowers.Com Inc shares are lower after reporting Q2 revenue of $293.1 million and a non-GAAP loss of $0.80 per share.

11 sep 2026, 20:09 UTC

News

Century Communities plans to open Grand Oaks of Callaway in Florida on September 26, featuring homes starting from the upper $200s. Shares are gaining.

11 sep 2026, 20:09 UTC

News

Columbia Sportswear appoints Peter Rauch as President of Mountain Hardwear, effective September 28. Shares are higher today, despite pulling back from an earlier session high.

11 sep 2026, 20:09 UTC

News

Clear Secure shares are lower after DA Davidson analyst Wyatt Swanson cut the price target to $45.00 from $55.00 while maintaining a Neutral rating.

11 sep 2026, 20:09 UTC

News

Carvana Co's shares are lower today, continuing a downward trend amid institutional investment activity and persistent inflation pressures indicated by recent CPI data.

11 sep 2026, 20:09 UTC

News

Ultragenyx Pharmaceutical shares are lower as Bronstein, Gewirtz & Grossman, LLC, initiates an investigation following disappointing Phase 3 study results for apazunersen.

11 sep 2026, 20:09 UTC

News
Social Media
Correlated Moves

Snowflake Inc. shares are declining amid insider selling by director Benoit Dageville, who sold 50,000 shares at $335.72 on September 9.

11 sep 2026, 20:09 UTC

News
Social Media

Advanced Micro Devices shares are higher today following positive growth projections for its server and data center businesses, potentially exceeding $65 billion by Q4 2026.

11 sep 2026, 20:09 UTC

News

Intercontinental Exchange sponsors the 9/11 Day of Service initiative. Shares are advancing during Friday's trading, reflecting positive momentum since Thursday's close.

11 sep 2026, 20:09 UTC

News
Social Media

Marvell Technology reports fiscal Q2 revenue of $2.73 billion, exceeding estimates. Shares are higher amid strong demand for AI networking and advanced technologies.

11 sep 2026, 20:09 UTC

News

D.R. Horton shares advance despite Wells Fargo lowering the price target to $145, amid concerns over declining demand in the homebuilding sector.

11 sep 2026, 20:09 UTC

Correlated Moves
News

Citigroup shares reached an eight-week high earlier today, reflecting positive investor sentiment. The stock remains higher since Thursday, supported by the S&P 500's advance.

11 sep 2026, 20:09 UTC

News
Social Media
Macro Event

Intel shares are higher today, bolstered by a Northland upgrade to Outperform and significant wafer processing milestones using ASML's High-NA EUV machines.

11 sep 2026, 20:09 UTC

Correlated Moves
Social Media
News

Coinbase shares are higher as CFO Alesia Haas outlines contingency plans for regulatory clarity amid rising Ethereum prices.

11 sep 2026, 20:09 UTC

Social Media
News

DA Davidson upgraded Palantir Technologies to Buy and raised its price target to $250, citing strong AI focus and positive market sentiment. Shares have gained since Thursday.

11 sep 2026, 20:09 UTC

News
Macro Event

Paysign shares are lower amid negative sentiment from insider selling and broader market pressures, including a decline in the Michigan Consumer Sentiment index.

11 sep 2026, 20:09 UTC

News

Visa has launched an onchain lending initiative with Credit Coop, financing $2.5 billion to address funding gaps from daily card settlements. Shares are higher today.

Peer Vergelijking

Prijswijziging

GlaxoSmithKline PLC Prognose

Koersdoel

By TipRanks

17.69% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 2,089.615 GBX  17.69%

Hoogste 3,010 GBX

Laagste 1,700 GBX

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor GlaxoSmithKline PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

15 ratings

2

Buy

10

Hold

3

Sell

Sentiment

By Acuity

113 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
help-icon Live chat